Jiabing Anzhi Pian (甲丙氨酯片)甲丙氨酯片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司
主要成分Active Ingredients
- 甲丙氨酯Jiabing Anzhi
药物知识说明
甲丙氨酯是一种在国家药监局注册认定的药品。该药品含有甲丙氨酯-ae4e0eef等成分。
该药品关联的活性成分包括：甲丙氨酯Jiabing Anzhi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司。
您可以探索含有相同成分的其他药品：甲丙氨酯-ae4e0eef成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 甲丙氨酯片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 甲丙氨酯Jiabing Anzhi.
Manufacturers recorded for this product: 西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司.
Explore other medicines containing the same ingredient: 甲丙氨酯 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 甲丙氨酯片Recorded Chinese name: 甲丙氨酯片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.2g0.2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H61022416
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H61022416
Manufacturer
Chinese legal name: 西安利君制药有限责任公司
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H61022416
生产企业
西安利君制药有限责任公司
适应症
1．治疗焦虑性神经症，缓解焦虑、紧张、不安、失眠等症状。|2．治疗失眠症。|3．治疗肌张力过高或肌肉僵直的疾病。|4．癫痫小发作。
用法用量
1.口服抗焦虑：一次200mg，一日2～3次。|2.治疗失眠：400mg睡前服用。|3.治疗癫痫：一次200～400mg，一日2～3次。
不良反应
尚不明确。
禁忌
白细胞减少者及对本品过敏者。
注意事项
1．长期使用可产生依赖性。若停药必须逐渐减量，若骤停可产生撤药综合征，表现为失眠、呕吐、震颤、肌肉抽搐、焦虑、动作失调等，甚至出现幻觉、惊厥。|2．肾功能不全者、肺功能不全者慎用。|3．定期检查肝功能与白细胞计数。|4．用药期间不宜驾驶车辆、操作机械或高空作业。|5．服药期间勿饮酒。
贮藏
密封，置阴凉处。
规格
0.2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.